Clinical Trials Directory

Trials / Completed

CompletedNCT03725228

Lidocaine Compared to Magnesium Sulfate to Prolong Spinal Anesthesia: Non-inferiority Randomized Clinical Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Brasilia University Hospital · Academic / Other
Sex
All
Age
18 Years – 120 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the addition of continuous infusion of lidocaine or continuous infusion of magnesium sufate in the duration of spinal anesthesia.

Detailed description

Both lidocaine and magnesium sulfate have been shown to prolong spinal anesthesia. The number of studies using magnesium sulfate to improve spinal anesthesia is greater than the number of studies using lidocaine, and methodology varies significantly between studies. Adverse effects of lidocaine are different from magnesium sulfate's. Lidocaine has a wider therapeutic interval with fewer side effects, including: Drowsiness, Feeling Anxious, Feeling Cold, Nervous, Numbness And Tingling, Signs And Symptoms At Injection Site, Twitching. Magnesium sulfate's side effects include: heart disturbances, breathing difficulties, poor reflexes, confusion, weakness, flushing (warmth, redness, or tingly feeling), sweating, lowered blood pressure, feeling like you might pass out, anxiety, cold feeling, extreme drowsiness, muscle tightness or contraction, or headache.

Conditions

Interventions

TypeNameDescription
DRUGMagnesium SulfateMagnesium Sulfate 15mg/kg/h
DRUGLidocaineLidocaine 1,5mg/kg/h

Timeline

Start date
2018-11-07
Primary completion
2019-02-01
Completion
2019-04-01
First posted
2018-10-30
Last updated
2020-02-27

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03725228. Inclusion in this directory is not an endorsement.